An international study has shown that a drug called selumetinib can reduce the pain and size of tumors caused in adults by ...

The exact cause of AVMs is not known. Experts believe that they can result from developmental errors that occur during ...

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ...

The STAAR trial showed that a one-shot dose of ST-920 – now known as isaralgagene civaparvovec – was able to improve kidney ...

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

Recessive dystrophic epidermolysis bullosa (RDEB) is a systemic disease of poor mucocutaneous basement membrane integrity downstream of bi-allelic pathogenic variants in COL7A1. Cutaneous clinical ...

A panelist discusses how real-world experience with ruxolitinib and belumosidil shows similar response rates to clinical ...

New guidelines, developed and led by experts at the University of Nottingham, will help clinicians to better treat the ...

Face yoga has gained online popularity in recent years for its promised antiaging, face slimming effects, but does it ...

To really “ eat your retinol ,” you have to eat foods that contain something called “preformed retinol,” which does not have ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...